NCT05553067View on ClinicalTrials.gov

Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

June 1, 2022

Conditions

Ovarian Neoplasms

Interventions

GENETIC

Immunohistochemical staining of normal and neoplastic ovarian tissues by anti human Engrailed-2 antibody.

Immunohistochemical staining of normal and neoplastic ovarian tissues by anti human Engrailed-2 antibody and compare levels of expression in different ovarian specimens to detect its potential role in oncogenesis of ovarian carcinoma.

Trial Locations (1)

82524

Sohag faculty of medicine, Sohag

All Listed Sponsors

lead

Sohag University

OTHER

NCT05553067 - Oncogenic Role of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms | Biotech Hunter | Biotech Hunter